Vaccines R&D and Commercialisation Congress: Asia

Vaccines R&D and Commercialisation Congress: Asia is organized by Global Engage Sdn Bhd - Asia Pacific Office and will be held from Nov 27 - 28, 2018 at Singapore.

This congress will look into vaccine development, its progression and commercialisation in Asia with leading experts share their insights and strategies that will enable you to fully characterise cell-level immunology, develop effective prognostic and predictive biomarkers, and understand the status of immune system.

The conference is part of Global Engage’s successful Drug Discovery series which includes our Precision Medicine, Medicinal Chemistry, and Synthetic Biology congresses.

Attracting industry and academic experts working in all areas of immunology, virology, cell biology and molecular biology, this two-day interactive meeting offers you an outstanding opportunity to meet and network with your peers on vaccine development, its progression and commercialisation in Asia. Leading experts share their insights and strategies that will enable you to fully characterise cell-level immunology, develop effective prognostic and predictive biomarkers, and understand the status of immune system. The meeting combines plenary sessions, set presentations, case studies, and panel discussions where your participates is encouraged.

Additional details will be posted as soon as they are available.